Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant seeks US OK for cobalt chromium stent:

This article was originally published in Clinica

Executive Summary

Guidant has submitted to the US FDA a premarket approval (PMA) application for permission to market its Multi-Link Vision coronary stent system. The device, the company's seventh-generation Multi-Link stent platform for the treatment of coronary artery disease, is constructed of a cobalt chromium alloy, enabling the stent to have thinner stent struts and enhanced deliverability while maintaining "excellent" radial strength and visibility, says the firm. The company plans to use cobalt chromium stents in future drug eluting stent platforms.

Topics

UsernamePublicRestriction

Register

MT068696

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel